Mebrofenin Pregnancy and Breastfeeding Warnings
Mebrofenin is also known as: Choletec
Mebrofenin Pregnancy Warnings
Animal reproduction studies have not been conducted.
It is not known whether Tc99m mebrofenin can cause fetal harm when administered to a pregnant woman or if it can affect reproductive capacity.
FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
FDA pregnancy category: C
Use mebrofenin only if clearly needed and benefit outweighs potential risk.
Mebrofenin Breastfeeding Warnings
The manufacturer recommends substitution of formula feedings for breast feedings.
Breast-feeding is not recommended.
Excreted into human milk: Yes
Excreted into animal milk: Unknown
The effects in the nursing infant are unknown.
References for pregnancy information
- "Product Information. Choletec (mebrofenin)." Bracco Diagnostics Inc, Princeton, NJ.
References for breastfeeding information
- "Product Information. Choletec (mebrofenin)." Bracco Diagnostics Inc, Princeton, NJ.
See Also...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
